GlobeNewswire

WSO2 Delivers Platform-Wide Support for GDPR with New Product Developments

Dela
WSO2 cloud-native, open source platform empowers enterprises to rapidly comply with EU data privacy requirements and create new GDPR-driven digital business offerings

MOUNTAIN VIEW, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Time is running out to comply with the General Data Protection Regulation (GDPR) that goes into effect May 2018. Mandated by the European Parliament and European Union (EU) Council, the regulation is aimed at harmonizing data privacy laws across Europe to protect all data belonging to citizens and residents. As a result, it affects any enterprise that conducts business in or with EU markets. Significantly, in addressing GDPR's requirements, organizations have an opportunity to set the stage for new digital business models that drive revenues and growth. To support these enterprises, WSO2 today announced its Spring 2018 Release update, featuring product developments designed to offer platform-wide support for GDPR.

WSO2's Spring 2018 Release includes new features and updates across all products, solutions, and services, which together empower organizations to rapidly comply with GDPR. Among these are additions to WSO2's identity access management (IAM), API management, enterprise integration, and analytics offerings designed to ensure the security and privacy of personal data throughout the processes of collection, processing, storage, and destruction.

By delivering its functionality on a cloud-native, open source platform, WSO2 facilitates the agility and innovation required to thrive in rapidly evolving markets driven by disruptive technologies and digital business models. Now with WSO2's platform-wide support for GDPR, enterprises can accelerate their digital transformation efforts by capitalizing on data, insights and services generated through compliance with the regulation.

"In today's global economy, avoiding the GDPR data privacy mandate isn't an option. It will impact every organization worldwide that wants to engage with European residents online," said WSO2 CEO Tyler Jewell. "With our Spring 2018 Release, we are delivering the integrated products and services that will empower enterprises to comply with GDPR in as little as 60 days while laying the groundwork to deliver new digital products based on secure GDPR-compliant data."

In addition to the new product capabilities, WSO2 is offering a series of seven webinars to help organizations accelerate their GDPR compliance. To learn more about the GDPR implementation best practices covered in the webinars, as well as how to participate, visit https://wso2.com/solutions/regulatory-compliance/gdpr/#Events.

Facilitating GDPR Compliance
WSO2's Spring 2018 Release offers several technology developments designed not only to help organizations meet the regulatory requirements of GDPR, but also enhance their long-term growth potential through new services and greater efficiency.

Consent management and privacy toolkit in  WSO2 Identity Server enable enterprise data controllers to accelerate their organization's GDPR compliance. In addition to the new consent management functionality and the privacy toolkit, the Spring 2018 Release of WSO2 Identity Server also introduces personal information export capabilities and support for encrypting OpenID Connect identity tokens. Together, these new features address the different aspects of individual rights defined in GDPR, such as the "right to be forgotten" and the "right to personal data portability" among others, in order to ensure the protection of personal information.

Collaborative API and application lifecycle management with  WSO2 API Manager allows APIs and applications to be shared within and across organizations. The Spring 2018 product version also features the ability to anonymize user identities, in line with GDPR requirements to provide users with the right to be forgotten. If a user requests that personal data be removed from the system, organizations can anonymize that specific user's unique universal identification from multiple locations.

The API and application lifecycle management capabilities also can be deployed via a GDPR-compliant hybrid cloud solution that provides organizations a local gateway rather than a cloud API gateway. This lets users take advantage of the cloud's scalability and agility while ensuring that all API calls occur locally, thus increasing security and minimizing latency. Moreover, it is easy to maintain, since users simply supply their cloud credentials, and the gateway pulls the configuration and changes from the cloud.

Open source and GDPR-ready integration capabilities with  WSO2 Enterprise Integrator enable connections and data transformations across legacy systems, SaaS applications, services, and APIs. The Spring 2018 Release incorporates significant enhancements to scripting, caching, and analytics functionality that allow organizations to efficiently automate task execution and store data in a GDPR-compliant manner and gain insights into performance.

Streaming analytics capabilities with  WSO2 Stream Processor (formerly named WSO2 Data Analytics Server) empower organizations to derive meaningful insights with available data. The Spring 2018 version of the product includes functionality to support GDPR compliance, such as the ability to anonymize both login user information and any data stored in databases.

WSO2 Open Banking  for financial firms,  which launched in August 2017, complements today's new product releases by providing the functionality to comply with both GDPR and the European Union's second Payment Services Directive (PSD2). Security features that support full GDPR compliance include user consent, user profile management, and cookie handling, among others.

Enhanced Subscription Benefits
WSO2's Spring 2018 Release product developments are complemented by enhancements to WSO2 Subscription, WSO2's commercial offering, which features access to WSO2 Update for continuous delivery of bug fixes, security updates, and performance enhancements, along with WSO2 Support for 24x7 support. Among the enhanced WSO2 Subscription benefits are the increase of support lifetime for WSO2 product versions to 10 years; new installation options, including Docker images, Docker Compose, and Vagrant; and a new release of WSO2 Update Manager. In addition to the included solutions and services, WSO2 Subscription offers options for training, consulting, and WSO2 Managed Cloud services.

Enterprises also can take advantage of a free 15-day trial of WSO2 Subscription to assist users evaluating WSO2 products and services. A Free Trial Subscription provides access to an account management and solution architecture team, along with access to all Subscription benefits, including five hours of query support.

About WSO2
WSO2 is the #1 open source integration vendor. It offers a complete platform that enables businesses to integrate, manage, govern and process any application, data or system-on-premises or in the cloud. Enterprises and governments across the world rely on WSO2's consulting and subscriptions that accelerate the evolution of any digital native initiative. Today, over 450 enterprise customers representing the world's best brands, process more than 5 trillion transactions through WSO2 each year. Visit https://wso2.com to learn more.

Trademarks and registered trademarks are the properties of their respective owners.

PR Contact
Shifali Erasmus
Kinetic.PR, LLC for WSO2
shifali@kineticprllc.com
Mobile: 650-544-6424




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: WSO2, Inc. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development delays publication of its Annual Report for 2018 and changes date for the Annual General Meeting26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SWEDEN - 26 April 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that The Board of Directors has decided to delay the publication of its Annual Report for 2018. Karolinska Development has changed the date for the Annual General Meeting to June 26, 2019. The date for publication of the Annual Report for 2018 has been changed from April 26 to April 30, 2019. Karolinska Development has changed the date for the Annual General Meeting from June 4 to June 26, 2019. Notice to the Annual General Meeting will be published in a separate press release. For more information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, CFO, Karolinska Development AB Phone: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TO THE EDITORS About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investmen

Karolinska Development senarelägger publicering av årsredovisningen för 2018 och meddelar nytt datum för årsstämma26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 26 april 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen har beslutat att senarelägga publiceringen av årsredovisningen för 2018. Karolinska Development har ändrat datum för årsstämman till den 26 juni 2019. Publiceringen av årsredovisningen för 2018 flyttas från den 26 april till den 30 april 2019. Karolinska Development har ändrat datum för årsstämman från den 4 juni till den 26 juni 2019. Kallelse till årsstämman kommer att publiceras senare i ett separat pressmeddelande. För ytterligare information, vänligen kontakta: Viktor Drvota, vd, Karolinska Development AB Tel: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, finanschef, Karolinska Development AB Tel: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TILL REDAKTÖRERNA Om Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) är ett nordiskt investmentbolag inom life science. Bolaget fokuserar p

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPressmeddelande

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum